| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2022-09-09 FY | 2021-10-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $29.32M | $28.68M | $28.34M | $31.27M | – | $50.29M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $20.11M | $21.14M | $20.94M | $24.28M | – | $36.79M |
| R&D | – | – | – | – | – | – |
| SG&A | $2.89M | $4.42M | $4.24M | $5.00M | – | $5.20M |
| Operating Income | $15.17M | $15.05M | $14.69M | $15.97M | – | $13.50M |
| Interest Expense | $7.28M | $7.31M | $7.72M | $8.06M | – | $12.28M |
| Tax Expense | – | – | – | – | – | – |
| Net Income | $3.51M | $15.85M | $760.00K | $45.99M | – | $927.00K |
| EPS (basic) | 0.4700 | 2.1300 | 0.1000 | 6.5200 | 0.1700 | 0.1300 |
| EPS (diluted) | 0.4700 | 2.1300 | 0.1000 | 6.4500 | 0.1700 | 0.1300 |
| Shares (diluted) | $7.47K | $7.46K | $7.45K | $7.13K | – | $7.02M |